Humana Inc.(HUM)NASDAQ
Stock Performance & Returns
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
HUM | 48.82 B | 38.72x | 26.20% | 0.88% | $10.50 | 6.89% | 0.76 | 92.00% | $428.88 | $161.90 |
UNH | 359.88 B | 26.00x | 0.40% | 3.14% | $15.42 | 14.15% | 0.69 | 2.36% | $461.62 | $254.52 |
ELV | 89.95 B | 18.35x | 1.40% | 2.47% | $22.60 | 11.13% | 0.69 | 1.74% | $436.24 | $272.05 |
CNC | 33.60 B | -6.61x | 4.60% | -2.83% | $-10.29 | -20.36% | 0.71 | - | $69.36 | $28.24 |
MOH | 10.59 B | 1268.19x | -5.70% | -0.02% | $0.16 | -0.16% | 0.95 | - | $244.89 | $121.06 |
Peer Valuation & Performance Analysis
Peer group analysis for Humana Inc. (HUM) compared to its primary competitors (including UNH, ELV, CNC) reveals distinct metrics. HUM trades at a valuation discount relative to its competitors, with a P/E ratio of 38.7x versus the peer average of 326.5x (representing a 88% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, HUM's revenue growth of 26.2% exceeds the peer average of 0.2%, highlighting its competitive strength and market share gains. Additionally, its net margin of 0.9% is comparable to the peer average of 0.7%.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• HUM ranks #3 in P/E ratio, #1 in revenue growth, and #3 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-09-03 | $401.96 | $413.50 | $397.87 | $406.52 | 769,500 | +1.13% |
| 2026-09-02 | $395.67 | $408.30 | $395.00 | $400.97 | 1,138,200 | +1.34% |
| 2026-09-01 | $387.68 | $398.32 | $386.32 | $394.88 | 1,059,600 | +1.86% |
| 2026-08-31 | $385.36 | $388.49 | $382.11 | $383.23 | 1,019,900 | -0.55% |
| 2026-08-28 | $392.71 | $397.33 | $385.22 | $385.54 | 746,500 | -1.83% |
| 2026-08-27 | $386.67 | $397.00 | $386.45 | $392.63 | 899,300 | +1.54% |
| 2026-08-26 | $390.00 | $403.15 | $386.55 | $391.06 | 908,100 | +0.27% |
| 2026-08-25 | $388.99 | $390.00 | $380.95 | $389.71 | 954,800 | +0.19% |
| 2026-08-24 | $380.49 | $389.85 | $379.27 | $386.61 | 1,455,000 | +1.61% |
| 2026-08-21 | $381.69 | $387.98 | $378.63 | $378.88 | 1,143,600 | -0.74% |
| 2026-08-20 | $374.29 | $387.79 | $374.29 | $380.73 | 1,316,600 | +1.72% |
| 2026-08-19 | $385.00 | $387.61 | $371.50 | $378.02 | 1,141,300 | -1.81% |
| 2026-08-18 | $384.00 | $392.53 | $381.69 | $382.00 | 741,200 | -0.52% |
| 2026-08-17 | $386.52 | $387.09 | $380.06 | $384.31 | 756,600 | -0.57% |
| 2026-08-14 | $384.00 | $389.70 | $380.09 | $389.05 | 761,100 | +1.32% |
Explore More Analysis for HUM
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.